Last reviewed · How we verify

NCT05139485

Evaluation of a Remote Asthma Monitoring Program to Improve Health Outcomes in Pediatric Asthma

Terminated Last updated 17 August 2025
What this trial tests

trial in Asthma in Children in 12 participants. Terminated before completion.

Timeline
10 June 2021
Primary endpoint
23 March 2023
23 March 2023

Quick facts

Lead sponsorWeill Medical College of Cornell University
StatusTerminated
Study typeOBSERVATIONAL
Enrollment12
Start date10 June 2021
Primary completion23 March 2023
Estimated completion23 March 2023
Sites1 location across United States

Conditions studied

Sponsor

Weill Medical College of Cornell University

Who can join

Adults 3 to 21, any sex, with Asthma in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this pilot study to is to determine the overall impact of a clinical program of remote medication monitoring administered by St. Mary's Homecare on disease control in pediatric asthma patients. The central hypothesis is that a short-term program of remote asthma medication monitoring paired with home visits and asthma education will be associated with a sustained improvement in asthma symptom control in children over time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Asthma in Children

Currently open trials in the same condition.

Other Weill Medical College of Cornell University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05139485.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing